Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

0.2070
-0.0130-5.91%
Pre-market: 0.21220.0052+2.51%08:02 EDT
Volume:1.30M
Turnover:270.15K
Market Cap:25.87M
PE:-0.14
High:0.2298
Open:0.2200
Low:0.1997
Close:0.2200
Loading ...

Vor Biopharma Inc. Conducted Annual Stockholders Meeting

Reuters
·
24 May

Vor Biopharma Appoints CEO Robert Ang as Principal Financial and Accounting Officer

Reuters
·
21 May

Vor Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Vor Biopharma (VOR) Receives a Buy from Evercore ISI

TIPRANKS
·
13 May

Vor Biopharma Cut to Market Perform From Market Outperform by JMP Securities

Dow Jones
·
09 May

HC Wainwright Downgrades Vor Biopharma to Neutral From Buy

MT Newswires Live
·
09 May

Vor Biopharma Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
09 May

Vor Biopharma Inc : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
09 May

BRIEF-Vor Biopharma Terminates CFO Han Choi

Reuters
·
08 May

BRIEF-Vor Bio Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value

Reuters
·
08 May

Wedbush Downgrades Vor Biopharma to Neutral From Outperform, Adjusts Price Target to $0.40 From $7

MT Newswires Live
·
08 May

Vor Biopharma Inc : Wedbush Cuts to Neutral From Outperform; Cuts Target Price to $0.40 From $7

THOMSON REUTERS
·
08 May

Dow Jumps Over 200 Points; US Initial Jobless Claims Fall

Benzinga
·
08 May

Vor Bio Winding Down Operations, Cutting Workforce, Exploring Potential Sale

Dow Jones
·
08 May

Vor Biopharma Inc - Terminates CFO Han Choi and Cso Tirtha Chakraborty - SEC Filing

THOMSON REUTERS
·
08 May

Vor Biopharma Inc - Wind Down Costs Estimated at $19.3 Million - SEC Filing

THOMSON REUTERS
·
08 May

Vor Biopharma Inc - Bio Implements 95% Workforce Reduction Costing $10.9 Million

THOMSON REUTERS
·
08 May

Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

THOMSON REUTERS
·
08 May

Vor Biopharma Inc: Also Winding Down Its Clinical and Manufacturing Operations, Beginning Immediately, Including Its Ongoing Clinical Trials

THOMSON REUTERS
·
08 May

Vor Biopharma Inc: Plans to Retain About 8 Employees to Assist in Exploring Strategic Alternatives

THOMSON REUTERS
·
08 May